top of page

PREVAIL IV – a trial to investigate if GS-5734 eliminates Ebola virus from semen

PREVAIL IV, a trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola RNA in their semen, has opened.

Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/42230/news/industry-news/prevail-iv-gs-5734-ebola/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page